<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03254914</url>
  </required_header>
  <id_info>
    <org_study_id>BR-FMS-OS-403</org_study_id>
    <nct_id>NCT03254914</nct_id>
  </id_info>
  <brief_title>Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE Study</brief_title>
  <official_title>A Multi-center, Cluster-randomized, Prospective, Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boryung Pharmaceutical Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boryung Pharmaceutical Co., Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of home blood pressure monitoring on
      controlling blood pressure and correlation between home blood pressure and clinic blood
      pressure in hypertensive patients receiving two or more concomitant antihypertensive agents
      including fimasartan
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A multi-center, cluster-randomized, prospective, observational study
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 9, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Weeks</target_duration>
  <primary_outcome>
    <measure>Rate of reaching target blood pressure</measure>
    <time_frame>12 weeks after treatment</time_frame>
    <description>Rate of reaching target blood pressure after treatment for 12 weeks</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">4320</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Control Site</arm_group_label>
    <description>Measure Clinic Blood Pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Site</arm_group_label>
    <description>Measure Clinic Blood Pressure and Home Blood Pressure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Home Blood Pressure</intervention_name>
    <description>Measure Home Blood Pressure</description>
    <arm_group_label>Test Site</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Hypertensive patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who voluntarily signed informed consent for participating in this clinical
             study

          -  Male and female over the age of 19

          -  Hypertensive patients receiving two or more concomitant anti-hypertensive agents
             including fimasartan

        Exclusion Criteria:

          -  Renal dialysis patients.

          -  Diabetic nephropathy patients taking angiotensin-converting enzyme inhibitor.

          -  Severe renal disorder

          -  Subjects with hereditary disorders of galactose intolerance, Lapp lactase deficiency
             or glucose-galactose malabsorption.

          -  Medical history with hypersensitivity to Fimasartan

          -  Pregnant women or lactating female.

          -  Participate in another clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hae-young Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hyung-jin Jung, MD</last_name>
    <phone>82-2-708-8233</phone>
    <email>hjjung@boryung.co.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul national university hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hae-young Lee, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2017</study_first_submitted>
  <study_first_submitted_qc>August 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2017</study_first_posted>
  <last_update_submitted>August 17, 2017</last_update_submitted>
  <last_update_submitted_qc>August 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Home Blood Pressure</keyword>
  <keyword>Fimasartan</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

